Literature DB >> 24106216

Efficacy of crosslinking on tailoring in vivo biodegradability of fibro-porous decellularized extracellular matrix and restoration of native tissue structure: a quantitative study using stereology methods.

Krishna Burugapalli1, Jeffrey C Y Chan, John L Kelly, Abhay S Pandit.   

Abstract

Cholecyst-derived extracellular matrix (CEM) is a fibro-porous decellularized serosal layer of porcine gall-bladder. CEM loses 90% of its weight at 48 h of in vitro collagenase digestion, but takes two months to be completely resorbed in vivo. Carbodiimide (EDC) crosslinking helps tailoring CEM's in vitro collagenase susceptibility. Here, the efficacy of EDC crosslinking on tailoring in vivo biodegradability of CEM is reported. CEM crosslinked with 0.0005 and 0.0033 × 10(3) M of EDC/mg that lose 80% and 0% of their weight respectively to in vitro collagenase digestion, were present even after 180 days in vivo. Quantitative histopathology using stereology methods confirmed our qualitative observation that even a tiny degree of crosslinking can significantly prolong the rate of in vivo degradation and removal of CEM.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biodegradation; cholecyst-derived extracellular matrix; crosslinking; stereology; tissue-implant interactions

Mesh:

Substances:

Year:  2013        PMID: 24106216     DOI: 10.1002/mabi.201300195

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  2 in total

1.  To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices.

Authors:  Luis M Delgado; Yves Bayon; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Tissue Eng Part B Rev       Date:  2015-03-12       Impact factor: 6.389

2.  A porcine-cholecyst-derived scaffold for treating full thickness lacerated skin wounds in dogs.

Authors:  Satheesan Karthika; Sainulabdeen Anoop; C B Devanand; M K Narayanan; Madhavan Unni; Saji Eassow; Thapasimuthu Anilkumar
Journal:  Vet Res Commun       Date:  2018-08-01       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.